Neo-Synalar Interactions
There are 68 drugs known to interact with Neo-Synalar (fluocinolone/neomycin topical), along with 7 disease interactions. Of the total drug interactions, 68 are moderate.
- View all 68 medications that may interact with Neo-Synalar
- View Neo-Synalar disease interactions (7)
Most frequently checked interactions
View interaction reports for Neo-Synalar (fluocinolone / neomycin topical) and the medicines listed below.
- acetaminophen / hydrocodone
- acetaminophen / oxycodone
- Aczone (dapsone topical)
- Align (bifidobacterium infantis)
- amitriptyline
- amlodipine
- amlodipine / benazepril
- amoxicillin
- amoxicillin / clavulanate
- Amzeeq (minocycline topical)
- apple cider vinegar
- Arnuity Ellipta (fluticasone)
- aspirin
- atorvastatin
- azithromycin
- Differin (adapalene topical)
- docusate
- hydroxyzine
- ketoconazole topical
- lorazepam
- magnesium oxide
- metformin
- MiraLAX (polyethylene glycol 3350)
- NuvaRing (ethinyl estradiol / etonogestrel)
- ProAir HFA (albuterol)
- spironolactone
- Vitamin D3 (cholecalciferol)
- Vraylar (cariprazine)
- Vyvanse (lisdexamfetamine)
- Zonegran (zonisamide)
Neo-Synalar disease interactions
There are 7 disease interactions with Neo-Synalar (fluocinolone / neomycin topical) which include:
- perforated tympanic membrane
- burns
- diabetes
- diaper rash
- hyperadrenocorticism
- infections
- ocular toxicities
More about Neo-Synalar (fluocinolone / neomycin topical)
- Neo-Synalar consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- Drug class: topical steroids with anti-infectives
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.